HRT Financial’s Lam Research LRCX Stock Holding History

HRT Financial’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.3M	Buy	+30,600	New	+$9.29M	0.02%	647
2026 Q1	–	Sell	-35,800	Closed	-$6.13M	–	4325
2025 Q4	$6.13M	Buy	+35,800	New	+$5.57M	0.02%	685
2025 Q3	–	Sell	-9,800	Closed	-$953K	–	3323
2025 Q2	$953K	Sell	9,800 -12,000	-55%	-$952K	﹤0.01%	1291
2025 Q1	$1.58M	Buy	+21,800	New	+$1.72M	0.01%	912
2024 Q3	–	Sell	-10,000	Closed	-$1.06M	–	2827
2024 Q2	$1.06M	Buy	+10,000	New	+$959K	0.01%	987
2023 Q2	–	Sell	-14,000	Closed	-$742K	–	2912
2023 Q1	$742K	Buy	+14,000	New	+$687K	0.01%	1115
2021 Q3	–	Sell	-29,000	Closed	-$1.89M	–	3553
2021 Q2	$1.89M	Buy	+29,000	New	+$1.83M	0.02%	655
2020 Q3	–	Sell	-19,000	Closed	-$614K	–	2163
2020 Q2	$614K	Buy	+19,000	New	+$518K	0.02%	713

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HRT Financial's LRCX Position: Q2 2026 in Review

HRT Financial reduced its Lam Research (LRCX) stake by 77% in Q2 2026, selling an estimated $200M and leaving 199,360 shares worth $86.4M. The position accounts for 0.16% of the portfolio, ranked #102.

HRT Financial first reported a position in LRCX in Q1 2018 and has held it in 22 quarters since. The position peaked at $183M in Q1 2026. 3,130 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

HRT Financial held 199,360 shares of Lam Research worth $86.4M as of Q2 2026.
HRT Financial sold 658,856 Lam Research shares in Q2 2026, an estimated $200M.
Lam Research made up 0.16% of HRT Financial's portfolio in Q2 2026, its #102 holding.
HRT Financial first reported a position in Lam Research in Q1 2018 and has held it in 22 quarters since.
HRT Financial's Lam Research position peaked at $183M in Q1 2026.
3,130 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.